Welcome to LookChem.com Sign In|Join Free
  • or
4-HYDROXY-6-(TRIFLUOROMETHYL)PYRIMIDINE-2-THIOL is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

368-54-7

Post Buying Request

368-54-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

368-54-7 Usage

General Description

4-Hydroxy-6-(trifluoromethyl)pyrimidine-2-thiol (HTPT) can form a stable monolayer on the Au(111) surface.

Check Digit Verification of cas no

The CAS Registry Mumber 368-54-7 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,6 and 8 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 368-54:
(5*3)+(4*6)+(3*8)+(2*5)+(1*4)=77
77 % 10 = 7
So 368-54-7 is a valid CAS Registry Number.

368-54-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (M2739)  2-Mercapto-6-(trifluoromethyl)-4-pyrimidinol  >98.0%(HPLC)(T)

  • 368-54-7

  • 1g

  • 750.00CNY

  • Detail
  • TCI America

  • (M2739)  2-Mercapto-6-(trifluoromethyl)-4-pyrimidinol  >98.0%(HPLC)(T)

  • 368-54-7

  • 5g

  • 2,650.00CNY

  • Detail
  • Alfa Aesar

  • (43873)  4-Hydroxy-6-(trifluoromethyl)pyrimidine-2-thiol, 97+%   

  • 368-54-7

  • 0.5g

  • 462.0CNY

  • Detail
  • Alfa Aesar

  • (43873)  4-Hydroxy-6-(trifluoromethyl)pyrimidine-2-thiol, 97+%   

  • 368-54-7

  • 2g

  • 1455.0CNY

  • Detail
  • Alfa Aesar

  • (43873)  4-Hydroxy-6-(trifluoromethyl)pyrimidine-2-thiol, 97+%   

  • 368-54-7

  • 10g

  • 5819.0CNY

  • Detail
  • Aldrich

  • (551821)  4-Hydroxy-6-(trifluoromethyl)pyrimidine-2-thiol  97%

  • 368-54-7

  • 551821-1G

  • 1,123.20CNY

  • Detail

368-54-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Hydroxy-6-(trifluoromethyl)pyrimidine-2-thiol

1.2 Other means of identification

Product number -
Other names 4(1H)-Pyrimidinone, 2,3-dihydro-2-thioxo-6-(trifluoromethyl)-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:368-54-7 SDS

368-54-7Relevant academic research and scientific papers

Design, synthesis and antitumor activity evaluation of trifluoromethyl-substituted pyrimidine derivatives

Liu, Limin,Wang, Zhengjie,Gao, Chao,Dai, Honglin,Si, Xiaojie,Zhang, Yang,Meng, Yaqi,Zheng, Jiaxin,Ke, Yu,Liu, Hongmin,Zhang, Qiurong

, (2021/09/14)

In order to find efficient new antitumor drugs, a series of novel trifluoromethyl-substituted pyrimidine derivatives were designed and synthesized, and the bioactivity against four human tumor cells (PC-3, MGC-803, MCF-7 and H1975) was evaluated by MTT assay. Compound 17v displayed potent anti-proliferative activity on H1975 (IC50 = 2.27 μΜ), which was better than the positive control 5-FU (IC50 = 9.37 μΜ). Further biological evaluation studies showed that compound 17v induced apoptosis of H1975 cells and arrested the cell cycle at G2/M phase. Furthermore, compound 17v induced H1975 cells apoptosis through increasing the expression of pro-apoptotic proteins Bax and p53 and down-regulating the anti-apoptotic protein Bcl-2. In addition, compound 17v was able to be tightly embedded in the active pocket of EGFR. In summary, these results demonstrated that compound 17v has a potential as a lead compound for further investigation.

Design, Synthesis, and Antitumor Activity Evaluation of Trifluoromethyl-Substituted Pyrimidine Derivatives Containing Urea Moiety

Chao, Gao,Heyi, Yan,Honglin, Dai,Hongmin, Liu,Jiaxin, Zheng,Lihong, Shan,Limin, Liu,Luye, Zhang,Na, Li,Qiurong, Zhang,Tao, Wang,Xiujuan, Liu,Yang, Zhang,Zhengjie, Wang

, p. 1301 - 1311 (2021/12/23)

Abstract: In order to find efficient new antitumor drugs, a series of novel pyrimidine derivatives containing urea moiety were designed and synthesized, and the antitumor activity of four human tumor cells was evaluated by MTT analysis. The results showed that most of the target compounds exhibited moderate antitumor activity. In particular, the IC50 (concentration required to achieve 50% inhibition of the tumor cell proliferation) value of compound 2-((4-(4-ethylphenoxy)-6-(trifluoromethyl)pyrimidin-2-yl)thio)-N-((4-ethylphenyl)carba-moyl)acetamide for MGC-803 (human gastric carcinoma cell line) was 2.51 ± 0.17 μmol L–1, the anti-proliferative activity was significantly better than the positive control drug 5-fluorouracil. Molecular docking revealed that this compound can bind well to the active site of epidermal growth factor receptor (EGFR), and it may become a potential antitumor drug.

Design, synthesis, and acaricidal activity of phenyl methoxyacrylates containing 2-alkenylthiopyrimidine

Hao, Shulin,Cai, Zengfei,Cao, Yangyang,Du, Xiaohua

, (2020/09/16)

A series of novel phenyl methoxyacrylate derivatives containing a 2-alkenylthiopyrimidine substructure were designed, synthesized, and evaluated in terms of acaricidal activity. The structures of the title compounds were identified by 1H NMR, 13C NMR and high-resolution mass spectra (HRMS). Compound (E)-methyl 2-(2-((2-(3,3-dichloroallylthio)-6-(trifluoromethyl)pyrimidin-4-yloxy) methyl)phenyl)-3-methoxyacr-ylate (4j) exhibited significant acaricidal activity against Tetranychus cinnabarinus (T. cinnabarinus) in greenhouse tests possessing nearly twice the larvicidal and ovicidal activity compared to fluacrypyrim. Furthermore, the results of the field trials demonstrated that compound 4j could effectively control Panonychuscitri with long-lasting persistence and rapid action. The toxicology data in terms of LD50 value confirmed that compound 4j has a relatively low acute toxicity to mammals, birds, and honeybees.

COMPOUNDS HAVING AGONISTIC EFFECT AGAINST GPR84, PREPARATION METHOD FOR COMPOUNDS AND USE OF COMPOUNDS

-

Paragraph 0155; 0156, (2018/09/12)

The present invention relates to a class of compounds represented by the formula I, or pharmaceutically acceptable salts thereof, methods for their preparation, and application as small molecule tools that function as GPR84 agonists, and their use in preparing a medicament for the treatment of septicemia.

Laccase-catalyzed green synthesis and cytotoxic activity of novel pyrimidobenzothiazoles and catechol thioethers

Abdel-Mohsen,Conrad,Harms,Nohr,Beifuss

, p. 17427 - 17441 (2017/03/31)

The laccase-catalyzed reaction between unsubstituted catechol and 2-thioxopyrimidin-4(1H)-ones using aerial O2 as the oxidant delivers novel pyrimidobenzothiazoles with high yields in an aqueous solvent system under mild reaction conditions. With 4-substituted catechols, catechol thioethers are formed exclusively. The synthetic protocols developed provide a sustainable approach for these compound classes. In addition, the cytotoxicity of the products against HepG2 cell line is reported. Most compounds exhibit antiproliferative activities with IC50 values at the micromolar level. A structure-activity relationship study will facilitate the further development of these compounds as cytotoxic agents.

Synthesis and evaluation of 5,6-disubstituted thiopyrimidine aryl aminothiazoles as inhibitors of the calcium-activated chloride channel TMEM16A/Ano1

Piechowicz, Katarzyna A.,Truong, Eric C.,Javed, Kashif M.,Chaney, Rachelle R.,Wu, Johnny Y.,Phuan, Puay W.,Verkman, Alan S.,Anderson, Marc O.

, p. 1362 - 1368 (2016/10/09)

Transmembrane protein 16A (TMEM16A), also called Ano1, is a Ca2+ activated Cl? channel expressed widely in mammalian epithelia, as well as in vascular smooth muscle and some tumors and electrically excitable cells. TMEM16A inhibitors have potential utility for treatment of disorders of epithelial fluid and mucus secretion, hypertension, some cancers and other diseases. 4-Aryl-2-amino thiazole T16Ainh-01 was previously identified by high-throughput screening. Here, a library of 47 compounds were prepared that explored the 5,6-disubstituted pyrimidine scaffold found in T16Ainh-01. TMEM16A inhibition activity was measured using fluorescence plate reader and short-circuit current assays. We found that very little structural variation of T16Ainh-01 was tolerated, with most compounds showing no activity at 10 μM. The most potent compound in the series, 9bo, which substitutes 4-methoxyphenyl in T16Ainh-01 with 2-thiophene, had IC50 ~1 μM for inhibition of TMEM16A chloride conductance.

Heteroannulation of 6-polyfluoroalkyl-2-thiouracils

Khudina,Ivanova,Burgart,Slepukhin,Saloutin,Chupakhin,Kravchenko

, p. 1060 - 1065 (2014/03/21)

A multi-component double Mannich cyclocondensation of 6-polyfluoroalkyl-2- thiouracils with formalin and heterocyclic amines (2-aminopyridine, 2-aminopyrimidine, 4-aminoantipyrine) proceeded regiospecifically at the C=S and NH centers giving rise to 3-hetaryl-8-polyfluoroalkylpyrimido[2,1-b][1,3,5] thiadiazines. The regioisomeric structure of the products was established by X-ray crystallography, IR and NMR spectroscopy, GLC-MS spectrometry. 6-Trifluoromethyl-2-thiouracil and 8-polyfluoroalkylpyrimido[2,1-b]thiadiazines exhibited weak tuberculostatic activity.

Substituted benzylamino-6-(trifluoromethyl)pyrimidin-4(1H)-ones: A novel class of selective human A-FABP inhibitors

Ringom, Rune,Axen, Eva,Uppenberg, Jonas,Lundb?ck, Thomas,Rondahl, Lena,Barf, Tjeerd

, p. 4449 - 4452 (2007/10/03)

The synthesis and evaluation of novel human A-FABP inhibitors based on the 6-(trifluoromethyl)pyrimidine-4(1H)-one scaffold is described. Two series of compounds, bearing either an amino or carbon substituent in the 2-position of the pyrimidine ring were

Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase

-

, (2008/06/13)

The subject invention relates to pyrimidine-thioalkyl and alkylether compounds of Formula (I) and pyrimidine-thioalkyl and alkylethers of Formula (IA), namely the compounds of Formula (I) where R 4 is selected from the group consisitng of --H or --NR 15 R 16 where R 15 is --H and R 16 is --H, C 1 -C 6 alkyl, NH 2 or R 15 and R 16 taken together with the --N form 1-pyrrolidino, 1-morpholino or 1-piperidino; and R 6 is selected from the group consisting of --H, or halo (preferably --Cl); with the overall proviso that R 4 and R 6 are not both --H. The compounds of Formula (IA) are useful in the treatment of individuals who are HIV positive being inhibitors of viral reverse transcriptase. STR1

Pyrimidine thioethers: A novel class of HIV-1 reverse transcriptase inhibitors with activity against BHAP-resistant HIV

Nugent, Richard A.,Schlachter, Stephen T.,Murphy, Michael J.,Cleek, Gary J.,Poel, Toni J.,Wishka, Donn G.,Graber, David R.,Yagi, Yoshihiko,Keiser, Barbara J.,Olmsted, Robert A.,Kopta, Laurie A.,Swaney, Steven M.,Poppe, Susan M.,Morris, Joel,Tarpley, W. Gary,Thomas, Richard C.

, p. 3793 - 3803 (2007/10/03)

A series of pyrimidine thioethers was synthesized and evaluated for inhibitory properties against wild-type HIV-1 reverse transcriptase (RT) and an RT carrying the resistance-conferring mutation P236L. Modifications of both the pyrimidine and the function

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 368-54-7